Free provider profile
KAILA COMPTON, M.D., Ph.D.
NPI 1073771598
Individual
Psychiatry & Neurology, Psychiatry
Active registration
Save to rep workspaceNPI registry Registry record
Source: CMS NPPES registry, updated continuously. This record was last updated 2008-05-30.
401 PARNASSUS AVE RTP OFFICE C/O SANDRA LIEU, SAN FRANCISCO, CA, 94143
415-203-3579
Single practice location
Enumerated 2008-05-30
- — Registration is active in NPPES.
- — Individual clinician record — reachable, but usually not the buyer.
- — Practice phone number is published.
- — Full street address on file for route planning.
- — Record last updated 18 years ago.
Medicare Part D prescribing
Source: CMS Medicare Part D Prescribers by Provider, most recent public year.
Part D claims
278
Medicare patients
22
Part D drug cost
$35,539
Brand-name share
9.7%
of this prescriber's Part D claims
| Drug | Claims | Medicare cost |
|---|---|---|
| Spravato (Esketamine Hcl) | 12 | $14,203 |
| Bupropion Xl (Bupropion Hcl) | 41 | $1,151 |
| Dextroamphetamine-Amphetamine (Dextroamphetamine/Amphetamine) | 20 | $495 |
| Venlafaxine Hcl Er (Venlafaxine Hcl) | 19 | $439 |
| Lamotrigine (Lamotrigine) | 24 | $359 |
| Desvenlafaxine Succinate Er (Desvenlafaxine Succinate) | 12 | $238 |
| Lorazepam (Lorazepam) | 19 | $192 |
| Sertraline Hcl (Sertraline Hcl) | 22 | $139 |
Want their full drug mix and peer benchmark? Run the free Part D prescriber lookup.
Spravato (esketamine) Medicare billing
Source: CMS Medicare Part B fee-for-service, HCPCS G2082/G2083.
2024348 sessions · 32 patients · $458,519
2023141 sessions · 21 patients · $177,835
Full Spravato label-compliance detail — sessions per patient against the FDA label, risk flags and year-over-year trend.
- Registry data comes straight from CMS NPPES, which lists registration, not activity — a listed practice may have moved or closed.
- Part D covers Medicare prescription drug enrollees only. Commercial, Medicaid and cash-pay prescribing is not included, so these figures are a floor on real volume, not the whole picture.
- CMS publishes the Part D file annually, roughly two years behind the prescribing year. Drugs with 10 or fewer claims are suppressed.